001     170190
005     20240229133707.0
024 7 _ |a 10.1093/jncics/pkab056
|2 doi
024 7 _ |a pmid:34377935
|2 pmid
024 7 _ |a pmc:PMC8346704
|2 pmc
024 7 _ |a altmetric:109509437
|2 altmetric
037 _ _ |a DKFZ-2021-01813
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wang, Xiaoliang
|0 0000-0001-5184-2935
|b 0
245 _ _ |a Association Between Smoking and Molecular Subtypes of Colorectal Cancer.
260 _ _ |a Oxford
|c 2021
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1637230724_29527
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Smoking is associated with colorectal cancer (CRC) risk. Previous studies suggested this association may be restricted to certain molecular subtypes of CRC, but large-scale comprehensive analysis is lacking.A total of 9789 CRC cases and 11 231 controls of European ancestry from 11 observational studies were included. We harmonized smoking variables across studies and derived sex study-specific quartiles of pack-years of smoking for analysis. Four somatic colorectal tumor markers were assessed individually and in combination, including BRAF mutation, KRAS mutation, CpG island methylator phenotype (CIMP), and microsatellite instability (MSI) status. A multinomial logistic regression analysis was used to assess the association between smoking and risk of CRC subtypes by molecular characteristics, adjusting for age, sex, and study. All statistical tests were 2-sided and adjusted for Bonferroni correction.Heavier smoking was associated with higher risk of CRC overall and stratified by individual markers (P trend < .001). The associations differed statistically significantly between all molecular subtypes, which was the most statistically significant for CIMP and BRAF. Compared with never-smokers, smokers in the fourth quartile of pack-years had a 90% higher risk of CIMP-positive CRC (odds ratio = 1.90, 95% confidence interval = 1.60 to 2.26) but only 35% higher risk for CIMP-negative CRC (odds ratio = 1.35, 95% confidence interval = 1.22 to 1.49; P difference = 2.1 x 10-6). The association was also stronger in tumors that were CIMP positive, MSI high, or KRAS wild type when combined (P difference < .001).Smoking was associated with differential risk of CRC subtypes defined by molecular characteristics. Heavier smokers had particularly higher risk of CRC subtypes that were CIMP positive and MSI high in combination, suggesting that smoking may be involved in the development of colorectal tumors via the serrated pathway.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Amitay, Efrat
|0 P:(DE-He78)6e02c183f41e45a5867dec393fb4616a
|b 1
|u dkfz
700 1 _ |a Harrison, Tabitha A
|0 0000-0002-4173-7530
|b 2
700 1 _ |a Banbury, Barbara L
|b 3
700 1 _ |a Berndt, Sonja I
|b 4
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 5
|u dkfz
700 1 _ |a Buchanan, Daniel D
|0 0000-0003-2225-6675
|b 6
700 1 _ |a Campbell, Peter T
|0 0000-0002-5549-2036
|b 7
700 1 _ |a Cao, Yin
|0 0000-0001-9835-7662
|b 8
700 1 _ |a Chan, Andrew T
|b 9
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 10
|u dkfz
700 1 _ |a Gallinger, Steven J
|b 11
700 1 _ |a Giannakis, Marios
|b 12
700 1 _ |a Giles, Graham G
|b 13
700 1 _ |a Gunter, Marc J
|0 0000-0001-5472-6761
|b 14
700 1 _ |a Hopper, John L
|b 15
700 1 _ |a Jenkins, Mark A
|0 0000-0002-8964-6160
|b 16
700 1 _ |a Lin, Yi
|b 17
700 1 _ |a Moreno, Victor
|0 0000-0002-2818-5487
|b 18
700 1 _ |a Nishihara, Reiko
|b 19
700 1 _ |a Newcomb, Polly A
|b 20
700 1 _ |a Ogino, Shuji
|0 0000-0002-3909-2323
|b 21
700 1 _ |a Phipps, Amanda I
|b 22
700 1 _ |a Sakoda, Lori C
|0 0000-0002-0900-5735
|b 23
700 1 _ |a Schoen, Robert E
|0 0000-0001-7153-2766
|b 24
700 1 _ |a Slattery, Martha L
|b 25
700 1 _ |a Song, Mingyang
|0 0000-0002-1324-0316
|b 26
700 1 _ |a Sun, Wei
|0 0000-0002-6350-1107
|b 27
700 1 _ |a Thibodeau, Steven N
|b 28
700 1 _ |a Toland, Amanda E
|0 0000-0002-0271-1792
|b 29
700 1 _ |a Van Guelpen, Bethany
|b 30
700 1 _ |a Woods, Michael O
|0 0000-0001-8180-418X
|b 31
700 1 _ |a Hsu, Li
|b 32
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 33
|u dkfz
700 1 _ |a Peters, Ulrike
|b 34
773 _ _ |a 10.1093/jncics/pkab056
|g Vol. 5, no. 4, p. pkab056
|0 PERI:(DE-600)2975772-1
|n 4
|p pkab056
|t JNCI cancer spectrum
|v 5
|y 2021
|x 2515-5091
909 C O |p VDB
|o oai:inrepo02.dkfz.de:170190
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)6e02c183f41e45a5867dec393fb4616a
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2020-09-11
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2020-09-11
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-09-11
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2020-09-11
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-09-11
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-09-11
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-09-11
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 2
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21